Table 1.
Demographic and clinical characteristics of patients included on presentation (N = 51)
| Demographics | |
|---|---|
| Sex, female, N (%) | 23 (45.1%) |
| Age, y, mean (SD) | 61.4 (17.7) |
| Past medical history | |
| Cardiovascular disease | 14 (27.5%) |
| Pulmonary disease | 12 (23.5%) |
| Diabetes mellitus | 10 (19.6%) |
| Chronic kidney disease | 6 (11.8%) |
| Immunosuppression | 8 (15.8%) |
| Hypertension | 20 (39.2%) |
| Malignancy | 13 (25.5%) |
| Symptoms | |
| Dyspnea | 29 (56.9%) |
| Fever | 23 (45.1%) |
| Myasthenia | 22 (43.1%) |
| Gastrointestinal symptoms | 10 (19.6%) |
| Cough | 22 (43.1%) |
| Ageusia/anosmia | 4 (7.8%) |
| Onset of symptoms, d | 3.5 (5.6) |
| Physical exam | |
| Systolic blood pressure (mm Hg) | 123.8 (18.5) |
| Diastolic blood pressure (mm Hg) | 72.8 (13.1) |
| Heart rate (bpm) | 94.9 (17.3) |
| Temperature (°C) | 36.5 (1.1) |
| O2 saturation (%) | 93 (5) |
| Respiratory rate (rpm) | 14.3 (4.1) |
| Laboratory results | |
| White blood cells, × 109/L | 7.22 (3.3) |
| Lymphocytes, × 109/L | 1.27 (0.8) |
| Creatinine, mg/ | 0.93 (0.49) |
| Urea, mg/dL | 45.2 (25.6) |
| Alanine transaminase, U/L | 57.8 (128.5) |
| Lactate dehydrogenase, U/L | 382.5 (291.9) |
| D-Dimer, ng/mL | 6870.9 (14,324) |
| C-Reactive protein, mg/dL | 72.0 (103.1) |
| Troponin I, ng/mL | 296.4 (1,285.3) |
| NT-proBNP, pg/mL | 2963.0 (2,837.9) |
| Interleukin-6, pg/mL | 214.5 (351.8) |
| Ferritin, ng/mL | 873.6 (1,567.5) |
| SARS-CoV-2 (RT-PCR) test | 48 (94.1%) |
| Positive | 23 (47.9%) |
| Negative | 23 (47.9%) |
| Indeterminate | 2 (4.2%) |
| Follow-up | |
| Admission | 34 (66.7%) |
| Intensive care unit | 4 (7.8%) |
| Discharge | 17 (33.3%) |
| Mortality | 6 (11.8%) |
NT-ProBNP = N-terminal pro-brain natriuretic peptide; RT-PCR = reverse transcriptase polymerase chain reaction; SARS-CoV-2 = Severe acute respiratory syndrome coronavirus 2.
Values are expressed as N (%) or mean (standard deviation).